Browsing by Author Tzallas, C.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 1 to 20 of 26  next >
TitleAuthor(s)Issue date
Apolipoproteins C-Ii and C-Iii and Small Dense Ldl Cholesterol Levels in Non-Diabetic Obese Subjects with Metabolic SyndromeFilippatos, T.; Tsimihodimos, V.; Kostapanos, M.; Kostara, C.; Tzallas, C.; Bairaktari, E.; Tselepis, A.; Elisaf, M.24-Nov-2015
The beneficial effect of tamoxifen on serum lipoprotein-A levels: an additional anti-atherogenic propertyElisaf, M. S.; Bairaktari, E.; Nicolaides, C.; Fountzilas, G.; Tzallas, C.; Siamopoulos, K.; Tsolas, O.; Pavlidis, N.24-Nov-2015
Comparison of the efficacy of atorvastatin and micronised fenofibrate in the treatment of mixed hyperlipidemiaMiltiadous, G.; Bairaktari, E.; Tzallas, C.; Tsimihodimos, V.; Liberopoulos, E.; Millionis, H.; Rizos, E.; Elisaf, M. S.24-Nov-2015
Current methodologies for the estimation of LDL-cholesterol in hemodialysis patients, based on homogeneous HDL-C, homogeneous LDL-C, immunoseparation LDL-C and ApoB assaysBairaktari, E.; Elisaf, M. S.; Tzallas, C.; Spheropoulos, G.; Pappas, M.; Tselepis, A.; Karabina, S. A.; Siamopoulos, K. C.; Tsolas, O.24-Nov-2015
Do LH-RH analogues induce effects similar to tamoxifen on serum lipid parameters in premenopausal women with breast cancer? A prospective studyElisaf, M. S.; Bairaktari, E.; Nicolaides, C.; Fountzilas, G.; Tzallas, C.; Tsolas, O.; Siamopoulos, K.; Pavlidis, N.24-Nov-2015
Effect of fluvastatin on plasma fibrinogen levelsLiberopoulos, E.; Tsimihodimos, V.; Bairaktari, E.; Tzallas, C.; Rizos, E.; Katsaraki, A.; Miltiadous, G.; Elisaf, M. S.24-Nov-2015
Effect of L-carnitine supplementation on lipid parameters in hemodialysis patientsElisaf, M. S.; Bairaktari, E.; Katopodis, K.; Pappas, M.; Sferopoulos, G.; Tzallas, C.; Tsolas, O.; Siamopoulos, K. C.24-Nov-2015
The effect of moxonidine on plasma lipid profile and on LDL subclass distributionElisaf, M. S.; Petris, C.; Bairaktari, E.; Karabina, S. A.; Tzallas, C.; Tselepis, A.; Siamopoulos, K. C.24-Nov-2015
Elevated interleukin-1 beta in the circulation of patients with essential hypertension before any drug therapy: a pilot studyDalekos, G. N.; Elisaf, M. S.; Papagalanis, N.; Tzallas, C.; Siamopoulos, K. C.24-Nov-2015
Estimation of LDL cholesterol based on the Friedewald formula and on apo B levelsBairaktari, E.; Hatzidimou, K.; Tzallas, C.; Vini, M.; Katsaraki, A.; Tselepis, A.; Elisaf, M.; Tsolas, O.24-Nov-2015
Evaluation of alternative calculation methods for determining low-density lipoprotein cholesterol in hemodialysis patientsBairaktari, E. T.; Tzallas, C.; Kalientzidou, M.; Tselepis, A. D.; Siamopoulos, K. C.; Seferiadis, K. I.; Elisaf, M. S.24-Nov-2015
Evaluation of five methods for determining low-density lipoprotein cholesterol (LDL-C) in hemodialysis patientsBairaktari, E.; Elisaf, M.; Tzallas, C.; Karabina, S. A.; Tselepis, A. D.; Siamopoulos, K. C.; Tsolas, O.24-Nov-2015
Evaluation of five methods for determining low-density lipoprotein cholesterol (LDL-C) in hemodialysis patients(1)Bairaktari, E.; Elisaf, M. S.; Tzallas, C.; Karabina, S. A.; Tselepis, A. D.; Siamopoulos, K. C.; Tsolas, O.24-Nov-2015
The incidence of thyroid function abnormalities in patients attending an outpatient lipid clinicTsimihodimos, V.; Bairaktari, E.; Tzallas, C.; Miltiadus, G.; Liberopoulos, E.; Elisaf, M. S.24-Nov-2015
The incidence of thyroid function abnormalities in patients attending an outpatient lipid clinicTsimihodimos, V.; Milionis, H.; Bairaktari, E.; Tzallas, C.; Miltiadous, G.; Katsaraki, A.; Liberopoulos, E.; Elisaf, M. S.24-Nov-2015
Increase of HDL-associated platelet-activating-factor acetylhydrolase (PAF-AH) activity but not of paraoxonase (PON1) during haemodialysisLiberopoulos, E.; Papavasiliou, E.; Tzallas, C.; Katopodis, K.; Gouva, C.; Christidis, D.; Tselepis, A.; Siamopoulos, K.; Elisaf, M.24-Nov-2015
Increased activity of PAF-acetylhydrolase in low density lipoprotein subfractions induces enhanced lysophosphatidylcholine production in patients with heterozygous familial hypercholesterolemiaElisaf, M. S.; Karabina, A. S.; Bairaktari, E.; Tzallas, C.; Siamopoulos, K. C.; Tselepis, A.24-Nov-2015
Increased activity of platelet-activating factor acetylhydrolase in low-density lipoprotein subfractions induces enhanced lysophosphatidylcholine production during oxidation in patients with heterozygous familial hypercholesterolaemiaKarabina, S. A. P.; Elisaf, M.; Bairaktari, E.; Tzallas, C.; Siamopoulos, K. C.; Tselepis, A. D.24-Nov-2015
Increased activity of platelet-activating factor acetylhydrolase in low-density lipoprotein subfractions induces enhanced lysophosphatidylcholine production during oxidation in patients with heterozygous familial hypercholesterolaemiaKarabina, S. A.; Elisaf, M. S.; Bairaktari, E.; Tzallas, C.; Siamopoulos, K. C.; Tselepis, A. D.24-Nov-2015
Investigation for the presence of anti-erythropoietin antibodies in patients with myelodysplastic syndromesVoulgari, P. V.; Hatzimichael, E. C.; Tsiara, S.; Tzallas, C.; Drosos, A. A.; Bourantas, K. L.24-Nov-2015